View Clinical Trial (Medical Research Study)
Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain - NCT00801086-85724(Clinical Trial 257081)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Tucson |
|
State:
|
|
AZ |
| Zip Code: |
|
85724 |
| Conditions: |
|
Alopecia |
| Purpose: |
|
Hair loss occurs commonly as a result of radiotherapy administered to the brain, and this
can contribute to the distress and social isolation of patients with advanced cancer. In
this study a topical gel will be applied directly to the scalp during each dose of
radiotherapy. The goal is to determine to what extent the experimental drug is successful in
lessening the hair loss.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Metastatic cancer to the brain for which palliative whole brain radiotherapy is
recommended.
- Hair that covers the scalp and is at least 1/4 inch in length
Exclusion Criteria:
- Receiving chemotherapy known to cause alopecia within 60 days of study or during the
study.
- Pre-existing alopecia
- Previous brain radiotherapy
- scalp metastases or scalp wounds
- use of hair dyes |
|
|
|
| Study is available at: |
|
University of Arizona
Tucson, AZ 85724
United States
Primary Contact:
Jamie Holt
Phone: 520-694-6000 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|